Takara Net Receivables from 2010 to 2026
| TF2 Stock | EUR 6.05 0.05 0.82% |
Net Receivables | First Reported 2016-12-31 | Previous Quarter 13.3 B | Current Value 8.9 B | Quarterly Volatility 4.5 B |
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
Takara | Net Receivables |
The Net Receivables trend for Takara Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Takara Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Takara Bio's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Takara Bio over the last few years. It is Takara Bio's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takara Bio's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Takara Net Receivables Regression Statistics
| Arithmetic Mean | 9,618,359,314 | |
| Geometric Mean | 9,152,843,623 | |
| Coefficient Of Variation | 33.83 | |
| Mean Deviation | 2,707,246,251 | |
| Median | 8,563,000,000 | |
| Standard Deviation | 3,254,089,134 | |
| Sample Variance | 10589096.1T | |
| Range | 10.1B | |
| R-Value | 0.81 | |
| Mean Square Error | 3907768.2T | |
| R-Squared | 0.65 | |
| Significance | 0.000085 | |
| Slope | 521,143,668 | |
| Total Sum of Squares | 169425537.5T |
Takara Net Receivables History
About Takara Bio Financial Statements
Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's Net Receivables, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 15.2 B | 10.8 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Takara Stock
Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.